InvestSMART

Company announcements

leave blank for all companies
leave blank for all announcements
announcements
Reset Filters
~ We have limited the announcement data displayed on our website to the past 12 months to ensure its accuracy and usefulness.
Search Results
Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Share Purchase Plan offer documents 30 Oct 2013 5:21PM $0.120 $18.000 risen by 14,900%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Appendix 4C - quarterly 30 Oct 2013 5:13PM $0.120 $18.000 risen by 14,900%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Orphan drug designation from FDA for NNZ-2566 in Fragile X 30 Oct 2013 10:21AM $0.120 $18.000 risen by 14,900%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Placement of $21.5m to accelerate execution of strategy 22 Oct 2013 9:54AM $0.125 $18.000 risen by 14,300%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Neuren receives Fast Track designation for Fragile X 18 Oct 2013 10:17AM $0.125 $18.000 risen by 14,300%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Trading Halt 18 Oct 2013 10:15AM $0.125 $18.000 risen by 14,300%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Response to ASX Price Query 9 Oct 2013 9:30AM $0.115 $18.000 risen by 15,552.17%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Neuren opens new IND for NNZ-2566 in Fragile X Syndrome 9 Sep 2013 11:24AM $0.100 $18.000 risen by 17,900%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Half Yearly Report and Accounts 29 Aug 2013 10:02AM $0.094 $18.000 risen by 19,048.94%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Response to social media commentary re Rett trial 5 Aug 2013 2:06PM $0.100 $18.000 risen by 17,900%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Trading Halt 5 Aug 2013 10:11AM $0.100 $18.000 risen by 17,900%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Appendix 4C - quarterly 31 Jul 2013 9:54AM $0.096 $18.000 risen by 18,650%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Results in Fragile X Model with NNZ 2591 29 Jul 2013 12:26PM $0.110 $18.000 risen by 16,263.64%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Response to ASX Price Query 26 Jul 2013 9:55AM $0.095 $18.000 risen by 18,847.37%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Neuren receives two new patents 12 Jul 2013 12:50PM $0.076 $18.000 risen by 23,584.21%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Response to ASX Price Query Letter 25 Jun 2013 9:31AM $0.074 $18.000 risen by 24,224.32%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 FDA Fast Track granted for NNZ2566 Rett program 5 Jun 2013 11:39AM $0.055 $18.000 risen by 32,627.27%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Response to ASX Price Query Letter 15 May 2013 2:32PM $0.046 $18.000 risen by 39,030.43%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Appendix 4C - quarterly 30 Apr 2013 10:24AM $0.032 $18.000 risen by 56,150%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Shareholder Update 15 Apr 2013 9:09AM $0.033 $18.000 risen by 54,445.45%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Preliminary Final Report 28 Feb 2013 11:23AM $0.039 $18.000 risen by 46,053.85%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Appendix 4C - quarterly 31 Jan 2013 9:29AM $0.035 $18.000 risen by 51,328.57%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Neuren IND open for Rett Phase II trial 24 Dec 2012 9:31AM $0.035 $18.000 risen by 51,328.57%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Neuren TAP Conference presentation and Fragile X results 30 Nov 2012 8:55AM $0.037 $18.000 risen by 48,548.65%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $2,282 Neuren completes Phase I NNZ2566 study/files Phase II IND 22 Nov 2012 9:21AM $0.039 $18.000 risen by 46,053.85%

651 - 675 of 822 results

Page 27 of 33

  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.